ATE177942T1 - Lösung, die igf-1 enthält - Google Patents

Lösung, die igf-1 enthält

Info

Publication number
ATE177942T1
ATE177942T1 AT94905282T AT94905282T ATE177942T1 AT E177942 T1 ATE177942 T1 AT E177942T1 AT 94905282 T AT94905282 T AT 94905282T AT 94905282 T AT94905282 T AT 94905282T AT E177942 T1 ATE177942 T1 AT E177942T1
Authority
AT
Austria
Prior art keywords
igf
pct
mmol
formulation
relates
Prior art date
Application number
AT94905282T
Other languages
English (en)
Inventor
Ebba Florin-Robertsson
Jonas Fransson
Diane Moore
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Application granted granted Critical
Publication of ATE177942T1 publication Critical patent/ATE177942T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
AT94905282T 1993-01-15 1994-01-10 Lösung, die igf-1 enthält ATE177942T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9300105A SE9300105D0 (sv) 1993-01-15 1993-01-15 Stable protein solution

Publications (1)

Publication Number Publication Date
ATE177942T1 true ATE177942T1 (de) 1999-04-15

Family

ID=20388550

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94905282T ATE177942T1 (de) 1993-01-15 1994-01-10 Lösung, die igf-1 enthält

Country Status (12)

Country Link
US (1) US5783559A (de)
EP (1) EP0679079B1 (de)
JP (1) JP3580816B2 (de)
AT (1) ATE177942T1 (de)
AU (1) AU676882B2 (de)
DE (1) DE69417397T2 (de)
DK (1) DK0679079T3 (de)
ES (1) ES2131673T3 (de)
GR (1) GR3030383T3 (de)
NZ (1) NZ259951A (de)
SE (1) SE9300105D0 (de)
WO (1) WO1994015584A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9502927D0 (sv) * 1995-08-24 1995-08-24 Pharmacia Ab Solution containing IGF-I
EP1538202B1 (de) * 1996-09-13 2014-01-22 Shire Human Genetic Therapies, Inc. Herstellung von menschlichen alpha-Galactosidase A
US6767892B1 (en) 1997-11-07 2004-07-27 Chrion Corporation Compositions providing for increased IGF-I solubility
EP1028748B1 (de) * 1997-11-07 2003-05-02 Chiron Corporation Zusammensetzung um die löslichkeit von igf-i zu erhöhen
BR9917606A (pt) 1998-11-06 2002-12-31 Bio Sidus S A Procedimento para a purificação de eritropoetina humana recombinante a partir de sobrenadantes de cultivo de células e eritropoetina humana recombinante obtida com tal procedimento
US6777205B1 (en) 1998-11-06 2004-08-17 Sterrenbeld Biotechnologie North America, Inc. Host cells expressing recombinant human erythropoietin
BR9905868A (pt) 1998-11-06 2001-01-23 Bio Sidus S A Procedimento de cultivo massivo de células de mamìfero para a obtenção de eritropoetina humana, recombinante e a eritropoetina humana recombinante obtida com tal procedimento
UY25790A1 (es) * 1998-11-06 2000-08-21 Bio Sidus S A Formas farmaceuticas de eritropoyetina humana recombinante estables a temperatura ambiente y apropiadas para su uso en humanos, formulaciones y procedimientos de liofilizacion para su obtencion.
CA2369451C (en) 1999-04-08 2009-09-22 Genentech, Inc. Composition based on oppositely-charged polypeptides
JP2001233787A (ja) * 2000-02-04 2001-08-28 Patents Exploitation Co Bv 小・中サイズのペプチド含有薬学的組成物
JP5000848B2 (ja) 2002-05-21 2012-08-15 第一三共株式会社 グレリン含有医薬組成物
CA2576473C (en) 2004-08-24 2015-06-30 Daiichi Asubio Pharma Co., Ltd. Liquid preparation of physiologically active peptide
US20110152188A1 (en) * 2009-12-23 2011-06-23 Hanns-Christian Mahler Pharmaceutical compositions of igf/i proteins
US11738068B2 (en) 2018-06-25 2023-08-29 Jcr Pharmaceuticals Co., Ltd. Protein-containing aqueous liquid formulation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4853224A (en) * 1987-12-22 1989-08-01 Visionex Biodegradable ocular implants
DE3939346A1 (de) * 1989-11-29 1991-06-06 Behringwerke Ag Arzneimitel zur subkutanen oder intramuskulaeren applikation enthaltend polypeptide
US5126324A (en) * 1990-06-07 1992-06-30 Genentech, Inc. Method of enhancing growth in patients using combination therapy
DE4126983A1 (de) * 1991-08-15 1993-02-18 Boehringer Mannheim Gmbh Verfahren zur herstellung von humanprotein-enthaltenden, konservierten arzneimitteln fuer infusions- oder injektionszwecke

Also Published As

Publication number Publication date
SE9300105D0 (sv) 1993-01-15
EP0679079A1 (de) 1995-11-02
DE69417397D1 (de) 1999-04-29
DK0679079T3 (da) 1999-10-11
AU676882B2 (en) 1997-03-27
AU5893994A (en) 1994-08-15
GR3030383T3 (en) 1999-09-30
NZ259951A (en) 1996-10-28
US5783559A (en) 1998-07-21
WO1994015584A1 (en) 1994-07-21
JPH08505617A (ja) 1996-06-18
EP0679079B1 (de) 1999-03-24
ES2131673T3 (es) 1999-08-01
DE69417397T2 (de) 1999-09-09
JP3580816B2 (ja) 2004-10-27

Similar Documents

Publication Publication Date Title
DE69417397T2 (de) Lösung, die igf-1 enthält
PT998288E (pt) Composicoes contendo capsaicina ou analogos de capsaicina e um anestesico local
ATE322283T1 (de) Transdermale verwendung von sekretin zur behandlung von autismus
ATE255450T1 (de) Matrix für iontophorese
ATE113213T1 (de) Gerät zur vorläufigen reperfusionsbehandlung von herzanfallsymptomen.
YU209288A (en) Process for producing compound for treating, which contains azelastin for use in nose and/or eye
DE69332713D1 (de) Verwendung von Histamine-2 Agonisten zur Behandlung sexueller Funktionsstörungen
NO972128D0 (no) 2,2-dikloralkankarboksylsyrer, fremgangsmåte for fremstilling av disse, legemiddel inneholdende disse og anvendelse derav for behandling av insulinresistens
Nanninga et al. Role of magnesium and calcium in the first and second contraction of glycerin-extracted muscle fibers
DE59509580D1 (de) Pharmazeutisches präparat enthaltend plasminogenaktivatoren
DE69522702D1 (de) Eine lagerstabile wässrige lösung zur infusion die einen thrombininhibitor enthält
DE69924483D1 (de) Kombinationstherapie zur behandlung von tumoren
ATE242641T1 (de) Behandlung von stressinduzierten hautkrankheiten unter verwendung von corticoliberin (crh)- antagonisten und inhibitoren der hautmastzell- degranulation
DE69231036T2 (de) Verfahren zur behandlung von patienten mit chronischer lebererkrankung
CA2153787A1 (en) Solution containing igf-1
JP2001187750A (ja) 感染部位検知方法、それに使用する組成物およびその組成物の製造方法
Kozlov The effect of carbon dioxide gas on the content of ammonia, glutamine, and urea in the blood of amimals after injection of solutions of ammonium chloride
BG94567A (en) Medicaments for the treatment of aids and method for its application
UA43413C2 (uk) Спосіб одержання ін'єкційного засобу "ерихрозид" для лікування серцево-судинних захворювань
ATE72397T1 (de) Pharmazeutische zusammensetzungen zur behandlung von hyperproliferativer hautkrankheit.
UA23999C2 (uk) Спосіб одержаhhя засобу "біпекс" для лікуваhhя hейрооhкологічhих захворюваhь
CA2165271A1 (en) Reduction of adipose tissue
UA30956A (uk) Спосіб лікування алергічного риніту
UA27060C2 (uk) Спосіб стимулюваhhя зовhішhьої секреції підшлуhкової залози
UA29106A (uk) Спосіб лікування вібраційної хвороби

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee